Skip to main content

Save $1 with Theraflu

open icon close icon

We all deserve

the right to recover

Rest and recovery shouldn’t be an issue of access

It’s impossible to have a flu-safe world if people go to work sick.

It’s simple - people need time to rest and recover. But we live in a “push through” culture that may punish people for taking time off. Many worry that if they call in sick, they’ll miss out on pay. So, while taking the time to rest and recover may be the wise choice, it's not as easy for those without a safety net. As barriers and life’s obligations mount, sickness becomes a cycle and rest remains out of reach.

When we’re sick, we deserve the right to rest and recover. It’s time to make rest a right, not a privilege.

Poet and activist Suzen Baraka’s Some Heroes tells us why rest is so important




For many families, it’s financially impossible to take even one day of unpaid sick time. Theraflu is partnering with Good+Foundation to create the Rest & Recover Fund – a $150,000 microgrant program designed to help offset lost wages from 1,000 unpaid sick days to support parents facing the financial and logistical challenges of taking a day to rest and recover from an unexpected mild illness.

Good+Foundation is a leading national non-profit that works to dismantle multigenerational poverty by pairing tangible goods with innovative services for low-income fathers, mothers, and caregivers, creating an upward trajectory for the whole family.

Theraflu’s 2021 Temperature Check

How does society feel about sick time and what are the pain points that keep people from taking time to rest and recover?

Future ambitions

Theraflu is fighting for a flu-safe future. The Rest & Recover Fund is a good starting point to help Americans get access to the rest and recovery they need. However, there’s still much more work to be done. Our goal is to continue challenging perceptions, providing support, and ultimately advocating for policy changes.

Because we won’t rest, until everyone can. 

*Statistics are based on the results of OnePoll’s survey of 2,000 employed Americans, conducted on behalf of Theraflu.